Drug intelligence / Profile preview

inositol 1,3,4,5-tetrakisphosphate

Development stage
Unknown
Modality
Small Molecules
01

Overview

Inositol 1,3,4,5-tetrakisphosphate (IP₄) is a naturally occurring small molecule and a member of the inositol polyphosphates family. It is produced by phosphorylation of inositol trisphosphates and acts as a second messenger involved primarily in cellular calcium signaling. IP₄ increases intracellular calcium levels by two distinct mechanisms: it can open calcium channels on the endoplasmic reticulum to release stored Ca²⁺ and also increase entry of Ca²⁺ across the plasma membrane[2][9][10]. It is functionally related to myo-inositol and plays roles as a metabolite and signaling molecule within cells[1][3]. In addition to its role as a second messenger for Ca²⁺ mobilization[8], it has been reported to act as an inhibitor or regulator of certain phosphatases involved in phosphoinositide metabolism[6]. Experimental evidence suggests that IP₄ may also interact with tyrosine-protein kinase BTK (Bruton's tyrosine kinase), although this mechanism remains less well characterized[4].

Other names
inositol 1,3,4,5-tetrakisphosphatemyo-inositol 1,3,4,5-tetrakisphosphateinositol 1,3,4,5-tetraphosphateD-myo-inositol 1,3,4,5-tetrakis(phosphate)102850-29-3
02

Targets

RASA3 (Ras GTPase-activating protein 3)BTK (Bruton tyrosine kinase)

Beyond the preview

Go deeper on inositol 1,3,4,5-tetrakisphosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on inositol 1,3,4,5-tetrakisphosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call